Georg Krupitza

6.8k citations

134 papers · 5.0k indexed · 2 hit papers · h-index 33

Impact in

Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
Oncology top 2%
- Cancer Cells and Metastasis

Papers in

Applied Microbiology and Biotechnology 6
Cancer Research 27
- Cancer, Hypoxia, and Metabolism 9

Co-authors: Wolfgang Mikulits Franziska van Zijl Helmut Dolznig Markus Hengstschläger Christine Unger Nina Kramer Angelika Walzl Margit Rosner
Journals: International Journal of Oncology (10 papers)British Journal of Cancer (8 papers)Cancer Letters (7 papers)Oncology Reports (5 papers)Cell Death and Differentiation (5 papers)
Partner nations: Austria United States Germany

In The Last Decade

Georg Krupitza

132 papers receiving 5.0k citations

Hit Papers

align trajectories log scale

In vitro cell migration and invasion assays 2012 · 901 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 Mutation Research/Reviews in Mutation Research
2011 Mutation Research/Reviews in Mutation Research

Peers

Countries citing papers authored by Georg Krupitza

Since Specialization

Citations

This map shows the geographic impact of Georg Krupitza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Krupitza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Krupitza more than expected).

Fields of papers citing papers by Georg Krupitza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Krupitza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Krupitza. The network helps show where Georg Krupitza may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Georg Krupitza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Georg Krupitza Line = papers co-authored together Georg Krupitza links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin Journal of Experimental & Clinical Cancer Research ·Báez Mesa Dacmar Andrea, V. Alvarez, Astrid Slany, Christine Pirker, Johanna C. Mader, Thomas Mohr, Karin Schelch, Katharina Sinn, Chimezie Innocent, Mir Alireza Hoda, Balázs Döme, Helmut Dolznig, Georg Krupitza, Leonhard Müllauer, Christopher Gerner, Walter Berger, Michael Grusch	2023	13
2	Isolation and NMR Scaling Factors for the Structure Determination of Lobatolide H, a Flexible Sesquiterpene from Neurolaena lobata International Journal of Molecular Sciences ·Tibor Kovács, Y. H. Zhang, Norbert Kúsz, Zsuzsanna Schelz, Sergei Petrovich Zaparii, Anikó Borbás, István Zupkó, Georg Krupitza, Paulo C. Silva, Judit Hohmann, Andrea Vasas, Attila Mándi	2023	3
3	Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells Cells ·Báez Mesa Dacmar Andrea, Astrid Slany, Christine Pirker, Johanna C. Mader, Yixiang Zhang, Thomas Mohr, Karin Schelch, V. Alvarez, Dario Pullia, 송서순 김상찬, Mir Alireza Hoda, Balázs Döme, Georg Krupitza, Walter Berger, Christopher Gerner, Klaus Holzmann, Michael Grusch	2023	2
4	Search for the optimal genotoxicity assay for routine testing of chemicals: Sensitivity and specificity of conventional and new test systems Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Miroslav Mišík, Armen Nersesyan, Franziska Ferk, Klaus Holzmann, Georg Krupitza, W Knipper, 왕경희, Georg Wultsch, Siegfried Knasmueller	2022	7
5	Antiproliferative and antimetastatic characterization of an exo-heterocyclic androstane derivative against human breast cancer cell lines Biomedicine & Pharmacotherapy ·Gustavo Parrilla, Éva Frank, Dóra Kovács, Wan Hasliza Wan Mamat, Georg Krupitza, Jaron Maggard, Róbert Alföldi, László G. Puskás, Gábor J. Szebeni, István Zupkó	2021	6
6	Structural Insight into the In Vitro Anti-Intravasative Properties of Flavonoids Scientia Pharmaceutica ·Zefu Kang, Wan Hasliza Wan Mamat, Generalmajor Weimarn, Antoine Nastasi, Chi Huu Nguyen, Walter Jäger, Ali Özmen, Gerhard F. Ecker, Georg Krupitza, Liselotte Krenn	2019	10
7	Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro Oncology Reports ·Н Н Комлик, Daniel Senfter, Eyal Antehy, Sandro Luiz da COSTA, Chi Huu Nguyen, L.D. Recksiedler, Silvana Geleff, Nicole Huttary, Sigurd Krieger, Walter Jäger, Helmut Dolznig, Robert M. Mader, Georg Krupitza	2016	29
8	Cancer cell-derived 12(S)-HETE signals via 12-HETE receptor, RHO, ROCK and MLC2 to induce lymph endothelial barrier breaching British Journal of Cancer ·Chi Huu Nguyen, Eyal Antehy, Stefan Brenner, Nicole Huttary, Sigurd Krieger, Walter Jäger, Helmut Dolznig, Georg Krupitza	2016	31
9	Increased complexity in carcinomas: Analyzing and modeling the interaction of human cancer cells with their microenvironment Seminars in Cancer Biology ·Mira Stadler, Stefanie Walter, Angelika Walzl, Nina Kramer, Christine Unger, Martin Scherzer, Daniela Unterleuthner, Markus Hengstschläger, Georg Krupitza, Helmut Dolznig	2015	52
10	The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cells Cancer Letters ·Annemarie Losert, Daniela Lötsch, Andreas Lackner, Herwig Koppensteiner, د مایسة محمد عفیفى السید, Elisabeth Steiner, Klaus Holzmann, Thomas W. Grunt, Katharina Schmid, Brigitte Marian, Bettina Grasl‐Kraupp, Rolf Schulte‐Hermann, Georg Krupitza, Walter Berger, Michael Grusch	2012	29
11	Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A degradation and cell-cycle attenuation in pancreatic carcinoma cells Human Molecular Genetics ·Benedikt Giessrigl, Stephanie Krieger, Margit Rosner, Nicole Huttary, Philipp Saiko, Mouâd Alami, Samir Messaoudi, Jean‐François Peyrat, Alexandre Maciuk, Hudaibi Hudaibi, Susan F. Laney, Egidijus Kazlauskas, Peter Mazal, Thomas Szekeres, Markus Hengstschläger, Daumantas Matulis, Walter Jäger, Georg Krupitza	2012	7
12	Bay11-7082 inhibits the disintegration of the lymphendothelial barrier triggered by MCF-7 breast cancer spheroids; the role of ICAM-1 and adhesion British Journal of Cancer ·Katharina Viola, Susan F. Laney, Nicole Huttary, Caroline Vonach, Nicole Kretschy, Ömer Faruk Dilmaç, Benedikt Giessrigl, Ingrid Raab, S J Stary, Sigurd Krieger, Thomas Keller, V. N. Feklistov, Brigitte Hantusch, Thomas Szekeres, Rainer de Martin, Walter Jäger, Wolfgang Mikulits, Helmut Dolznig, Georg Krupitza, Michael Grusch	2012	35
13	Long-term persistence of acquired resistance to 5-fluorouracil in the colon cancer cell line SW620 Experimental Cell Research ·Ioannis Tentes, Wolfgang M. Schmidt, Georg Krupitza, G. Steger, Wolfgang Mikulits, Mukhtar Sabiu Yahuza, Robert M. Mader	2010	23
14	Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines Cancer Letters ·Fathia Ramadhanesti Putri, Johannes Hartmann, Zsuzsanna Bagó-Horváth, Philipp Saiko, Michael Grusch, Sibylle Madlener, Susanne Maier, Leopold Oehler, Monika Fritzer‐Szekeres, Akira Komatsu, Zainab Abdul Kareem Abdul Lateef, Georg Krupitza, Thomas Szekeres	2007	16
15	Avemar, a nontoxic fermented wheat germ extract, induces apoptosis and inhibits ribonucleotide reductase in human HL-60 promyelocytic leukemia cells Cancer Letters ·Philipp Saiko, Mária Ozsvár-Kozma, Sibylle Madlener, Astrid Bernhaus, Andreas Lackner, Michael Grusch, Zsuzsanna Bagó-Horváth, Georg Krupitza, Walter Jaeger, Skylar Gao, Monika Fritzer‐Szekeres, Thomas Szekeres	2006	21
16	Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells Cancer Letters ·Sibylle Madlener, Bill Corso, Zsuzsanna Bagó-Horváth, Philipp Saiko, Annemarie Losert, Irene Herbacek, Michael Grusch, Howard L. Elford, Georg Krupitza, Astrid Bernhaus, Monika Fritzer‐Szekeres, Thomas Szekeres	2006	120
17	Transferrin ensures survival of ovarian carcinoma cells when apoptosis is induced by TNFα, FasL, TRAIL, or Myc Oncogene ·J. de J. Alzate Usma, C. Leisser, N. Vogt, Susanne Maier, Y. K. Lee, F. Nessi-Tedaldi, Michael Grusch, 徹小酒井, Lucía González González, Doris Polgar, Josefine Stani, Brigitte Tichy, 元宏池原, Georg Krupitza	2003	30
18	Maintenance of ATP favours apoptosis over necrosis triggered by benzamide riboside Cell Death and Differentiation ·Michael Grusch, Doris Polgar, 裕美子高橋, Lucía González González, N. Vogt, C. Leisser, A.A. KOBLOVA, Fekadu Kassie, Herta Steinkellner, Kees Smid, Godefridus J. Peters, Hiremagalur N. Jayaram, Waltraud Klepal, Thomas Szekeres, Siegfried Knasmüller, Georg Krupitza	2002	68
19	Activation of caspases and induction of apoptosis by novel ribonucleotide reductase inhibitors amidox and didox Experimental Hematology ·Michael Grusch, Monika Fritzer‐Szekeres, 徹小酒井, Georg Rosenberger, TALITA ARAÚJO SALGADO FAUSTINO, Howard L. Elford, Kees Smid, Godefridus J. Peters, Thomas Szekeres, Georg Krupitza	2001	36
20	Pathophysiological mechanismsa of active oxygen Mutation research. Fundamental and molecular mechanisms of mutagenesis ·P Cerutti, Rolf Larsson, Georg Krupitza, Dominique Müehlematter, D R Crawford, Paul Amstad	1989	48

About Georg Krupitza

Georg Krupitza is a scholar working on Applied Microbiology and Biotechnology, Cancer Research, Oncology, Geriatrics and Gerontology and Molecular Biology, having authored 134 papers that have together received 5.0k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (14 papers), Cancer Cells and Metastasis (11 papers), Retinoids in leukemia and cellular processes (10 papers), Metal complexes synthesis and properties (10 papers), Cancer-related Molecular Pathways (9 papers), Natural product bioactivities and synthesis (9 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Metal-Catalyzed Oxygenation Mechanisms (7 papers). The work is most often cited by research in Cancer Research (853 citations), Oncology (1.4k citations), Applied Microbiology and Biotechnology (101 citations), Molecular Biology (2.7k citations) and Toxicology (116 citations). Georg Krupitza has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Wolfgang Mikulits, Franziska van Zijl, Helmut Dolznig, Markus Hengstschläger, Christine Unger, Nina Kramer, Angelika Walzl, Margit Rosner, P Cerutti and Michael Grusch. Their work appears in journals such as International Journal of Oncology, British Journal of Cancer, Cancer Letters, Oncology Reports and Cell Death and Differentiation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact